Midven News

Two new faces have joined Birmingham-based venture capital specialists Midven’s growing team. Ben Reed, aged 21, and Joshua Rodger, aged 22, will support Midven’s investment management team in their roles as analysts.  Both of the new recruits have run social enterprises whilst at university through their involvement with Enactus. Enactus is an entrepreneurial community of […]

read more

Birmingham-based venture capital specialists Midven have recruited Jett Parker-Holland to their team of analysts. Jett, aged 23, from Droitwich, will support the investment management team in the decision-making process and day-to-day management duties. An Aston University graduate, Jett holds a Masters Degree with distinction in Investment Analysis, as well as a BSc in Mathematics and […]

read more

Antibody veteran joins new CEO as Crescendo redirects strategy to Oncology focus  Cambridge, UK: 17 November 2015 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics, today announced the appointment of Dr. Kevin Johnson as non-executive Chairman of the Board of Directors. The appointment is effective immediately. Dr. Johnson brings […]

read more

1 2 3 4